Publications

Plasma Biomarkers Ascertained with Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review
PU Tang, IH Wu, IH Lao, Wai Leong and CJ Hu Innovations in Digital Health, Diagnostics, and...
more
The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease
FB Jiao, Fang Yi, YY Wang, SZ Zhang, YJ Guo, WJ Du, Ya Gao, JJ Ren, HF Zhang, LX Liu, HF Song and...
more
The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease
CS Liang, KP Su, CL Tsai, JT Lee, CS Chu, TC Yeh, MW Su, GY Lin, YK Lin, HT Chu, CK Tsai and FC...
more
The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease
YW Cheng, MJ Chiu, YF Chen, TW Cheng, YM Lai and TF Chen Alzheimer's Research & Therapy (...
more
Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
HC Liu, WC Lin, MJ Chiu, CH Lu, CY Lin and SY Yang PLoS ONE 15(6): e0234519 https://journals....
more

Pages